bioRxiv Science⌕ Search

Biology subjects

Cardona, V.

Publications and source records attributed to Cardona, V..

2 recordsLinked to original sources

Notes on the diet and size of Cassiopea

Medusae of the genus Cassiopea are common components of tropical and subtropical coastlines globally. Despite the broad distribution of this benthic scyphozoan, much about their ecology remains poorly described. Here, we collected over 100 adult Cassiopea individuals from Panama, the eastern United States, Cuba, the Philippines, Italy and Australia to examine continuity and differences in their diet across space, and to investigate whether their unique lifestyle is reflected in their diet. We found the majority of prey items to be associated with the epibenthos. The recovered prey were supermajority crustaceans, mainly harpacticoid copepods, with pteropods, nematodes, and miscellaneous eggs common as secondary components. Within the gastrovascular cavity of a single medusa, we found up to 379 items. There was a limited relationship between medusa size and prey items. Location had an impact on gut content diversity and medusa size had a small impact on the number of taxa found within the gut. In some sites, prey were scarce or absent from all medusae sampled. Overall, we reaffirm the diet previously recorded for small medusae in Puerto Rico and show that similar components are common in large and small medusae from throughout the East and West Atlantic and the Philippines.

ecology↗

mRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens

Pollen-food allergy syndrome (PFAS) affects a significant proportion of the global population with a major health and socioeconomic impact. Patients are generally treated against the major sensitized allergen which does not warrant protection against cross-reactive allergens, leading to long and ineffective treatment regimens. For food allergies, patient guidelines rely on source avoidance, leading to dietary restrictions and reduced quality of life - in particular for those suffering from PFAS. To overcome these limitations, we introduce a novel allergy immunotherapy (AIT) approach utilizing consensus allergens and mRNA technology to achieve broader, safer, and faster desensitization in PFAS patients. We first designed a consensus allergen of orthologs of non-specific Lipid Transfer Proteins (cnsLTP-1) representing a broad spectrum of nsLTP allergens prevalent in food and pollen sources. CnsLTP-1 was delivered to naive BALB/c mice using mRNA-lipid nanoparticles (mRNA-LNP) as vehicle, or by a traditional protein formulation, to assess if it elicits broad protection against allergens from different sources. Immunization with both mRNA-LNP and protein formulations demonstrated that cnsLTP-1-specific IgGs could be induced, whilst the mRNA-LNP formulation notably avoided the induction of allergen-specific IgEs. The induced antibodies were capable of recognizing and binding to a variety of nsLTPs, and effectively blocked the binding of allergens by allergic patient serum IgEs. This study thus demonstrates that the presented AIT strategy, based on mRNA-LNP technology and consensus allergens, could find clinical utility by addressing the limitations of current AIT. Further development of this technology platform could pave the way for more effective and patient-friendly treatments for PFAS and other cross-reactive allergies.

bioengineering↗